Isomorphic Labs

“Isomorphic was incredibly oversubscribed to the tune of eight to 10 X. The majority of people did not get anything at all when they wanted huge amounts.”

“After we published this paper, Google's isomorphic, which is probably the coolest AI drug discovery company out there in terms of technology discovered it and contacted us through the website cold asking questions about it.”

“I think we'll have that whole Drug design engine ready in, you know, the next five plus five to 10 years, then you're right.”

“Well, look, I want to literally cure cancer. I know people said that's the cliche, but I actually, what we're building isomorphic is general purpose. So we're trying to build a platform, a drug design platform that will be applicable to any therapeutic area. S…”

“And this company, by the way, their first round of funding was six hundred million dollars to, as they spun it out of Google and DeepMind”

“There's isomorphic labs, Thrive is a very proud investor in which is alphabets, drug discovery And life sciences, AI portfolio.”

“Today we work with about 1300 biotech and pharma companies scientists at over 7000 academic institutions, universities, all, all around the world. And our software powers, you know, household names like Moderna and Sanofi and Eli Lilly and Regeneron, but also …”

“We're building up the platform right now, and it's, ah, we have great partnerships with Eli Lilly, I think you had, ah, the CEO speaking earlier, and Novartis, which are fantastic, and our own internal drug programs, and I think we'll be entering sort of pre-c…”

“And so we've now done over 50 companies we've invested in 12 countries. We just break through half a billion dollars in the UK alone with our investment in isomorphic last week”

“One is curing all diseases one day. Which I think we're going to do with isomorphic and the work we're doing there or our spin out, our drug discovery spin out.”

“I think something like isomorphic ends up being of that magnitude of margin scale, but at an order of magnitude or two orders of magnitude higher revenue.”

“Meta and Amazon do not have an isomorphic lab and Waymo sitting inside their business that suddenly pops to a couple hundred billion of market cap. And Google does have a few of those.”

“They've basically kept all the IP for AlphaFold III in Isomorphic. So Google is going to monetize the heck out of this capability. And what they made available was not open source code, but a web-based viewer that scientists for, quote, non-commercial purposes…”